Fig. 5From: Therapeutic effects of Lucilia sericata larval excretion/secretion products on Leishmania major under in vitro and in vivo conditionsThe number of viable J774A.1 cells treated with increasing doses of ES of Lucilia sericata larvae and Glucantime at 72 h of exposure. There were no significant differences between the treatments (P = 0.343)Back to article page